当前位置: X-MOL 学术Eur. Respir. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
European Respiratory Journal ( IF 24.3 ) Pub Date : 2017-09-01 , DOI: 10.1183/13993003.00582-2017
Antoni Torres 1, 2 , Michael S Niederman 2, 3 , Jean Chastre 4 , Santiago Ewig 5 , Patricia Fernandez-Vandellos 6 , Hakan Hanberger 7 , Marin Kollef 8 , Gianluigi Li Bassi 9 , Carlos M Luna 10 , Ignacio Martin-Loeches 11 , J Artur Paiva 12 , Robert C Read 13 , David Rigau 14 , Jean François Timsit 15 , Tobias Welte 16 , Richard Wunderink 17
Affiliation  

The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studies of epidemiology, diagnosis, empiric treatment, response to treatment, new antibiotics or new forms of antibiotic administration and disease prevention have changed old paradigms. In addition, important differences between approaches in Europe and the USA have become apparent. The European Respiratory Society launched a project to develop new international guidelines for HAP and VAP. Other European societies, including the European Society of Intensive Care Medicine and the European Society of Clinical Microbiology and Infectious Diseases, were invited to participate and appointed their representatives. The Latin American Thoracic Association was also invited. A total of 15 experts and two methodologists made up the panel. Three experts from the USA were also invited (Michael S. Niederman, Marin Kollef and Richard Wunderink). Applying the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methodology, the panel selected seven PICO (population–intervention–comparison–outcome) questions that generated a series of recommendations for HAP/VAP diagnosis, treatment and prevention. ERS/ESICM/ESCMID/ALAT evidence-based recommendations for HAP/VAP diagnosis, treatment and prevention http://ow.ly/dGhv30dAVoa

中文翻译:

国际 ERS/ESICM/ESCMID/ALAT 医院获得性肺炎和呼吸机相关性肺炎管理指南

关于医院获得性肺炎 (HAP) 和呼吸机相关性肺炎 (VAP) 的最新欧洲指南和工作组报告发表于近 10 年前。从那时起,已对 HAP 和 VAP 进行了进一步的随机临床试验,并获得了新的信息。流行病学、诊断、经验性治疗、治疗反应、新抗生素或新抗生素给药形式和疾病预防的研究已经改变了旧的范式。此外,欧洲和美国的方法之间的重要差异已经变得明显。欧洲呼吸学会启动了一个项目,为 HAP 和 VAP 制定新的国际指南。其他欧洲学会,包括欧洲重症监护医学学会和欧洲临床微生物学和传染病学会,被邀请参加并任命了他们的代表。拉丁美洲胸科协会也受邀参加。该小组共有 15 名专家和两名方法学家。还邀请了三位来自美国的专家(Michael S. Niederman、Marin Kollef 和 Richard Wunderink)。应用 GRADE(推荐分级、评估、制定和评价)方法,专家组选择了七个 PICO(人口-干预-比较-结果)问题,这些问题为 HAP/VAP 诊断、治疗和预防提出了一系列建议。ERS/ESICM/ESCMID/ALAT 基于证据的 HAP/VAP 诊断、治疗和预防建议 http://ow.ly/dGhv30dAVoa 该小组共有 15 名专家和两名方法学家。还邀请了三位来自美国的专家(Michael S. Niederman、Marin Kollef 和 Richard Wunderink)。应用 GRADE(推荐分级、评估、制定和评价)方法,专家组选择了七个 PICO(人口-干预-比较-结果)问题,这些问题为 HAP/VAP 诊断、治疗和预防提出了一系列建议。ERS/ESICM/ESCMID/ALAT 基于证据的 HAP/VAP 诊断、治疗和预防建议 http://ow.ly/dGhv30dAVoa 该小组共有 15 名专家和两名方法学家。还邀请了三位来自美国的专家(Michael S. Niederman、Marin Kollef 和 Richard Wunderink)。应用 GRADE(推荐分级、评估、制定和评价)方法,专家组选择了七个 PICO(人口-干预-比较-结果)问题,这些问题为 HAP/VAP 诊断、治疗和预防提出了一系列建议。ERS/ESICM/ESCMID/ALAT 基于证据的 HAP/VAP 诊断、治疗和预防建议 http://ow.ly/dGhv30dAVoa 专家组选择了七个 PICO(人口-干预-比较-结果)问题,为 HAP/VAP 的诊断、治疗和预防提出了一系列建议。ERS/ESICM/ESCMID/ALAT 基于证据的 HAP/VAP 诊断、治疗和预防建议 http://ow.ly/dGhv30dAVoa 专家组选择了七个 PICO(人口-干预-比较-结果)问题,为 HAP/VAP 的诊断、治疗和预防提出了一系列建议。ERS/ESICM/ESCMID/ALAT 基于证据的 HAP/VAP 诊断、治疗和预防建议 http://ow.ly/dGhv30dAVoa
更新日期:2017-09-01
down
wechat
bug